Matches in DBpedia 2014 for { <http://dbpedia.org/resource/PRX-07034> ?p ?o. }
Showing items 1 to 41 of
41
with 100 items per page.
- PRX-07034 abstract "PRX-07034 is a selective 5-HT6 receptor antagonist. It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.".
- PRX-07034 atcPrefix "none".
- PRX-07034 casNumber "?".
- PRX-07034 iupacName "N-[1-(5-chloro-2,3-dimethoxyphenyl)ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline".
- PRX-07034 pubchem "11532574".
- PRX-07034 thumbnail PRX-07034_structure.png?width=300.
- PRX-07034 wikiPageExternalLink 5415458-1.html.
- PRX-07034 wikiPageExternalLink Epixs-Experimental-Drug-PRX-07034-Shows-Potential-Benefit-on-Cognition-Obesity-10689.html.
- PRX-07034 wikiPageID "26483314".
- PRX-07034 wikiPageRevisionID "592867718".
- PRX-07034 atcPrefix "none".
- PRX-07034 c "21".
- PRX-07034 casNumber "?".
- PRX-07034 cl "2".
- PRX-07034 h "29".
- PRX-07034 hasPhotoCollection PRX-07034.
- PRX-07034 iupacName "N-[1-ethyl]-2-methylsulfonyl-5-piperazin-1-ylaniline".
- PRX-07034 legalStatus "Uncontrolled".
- PRX-07034 molecularWeight "490.44".
- PRX-07034 n "3".
- PRX-07034 o "4".
- PRX-07034 pubchem "11532574".
- PRX-07034 routesOfAdministration "Oral".
- PRX-07034 s "1".
- PRX-07034 smiles "COc2ccccCNc1ccN3CCNCC3".
- PRX-07034 verifiedrevid "424987327".
- PRX-07034 subject Category:Anilines.
- PRX-07034 subject Category:Organochlorides.
- PRX-07034 subject Category:Phenol_ethers.
- PRX-07034 subject Category:Piperazines.
- PRX-07034 type Drug.
- PRX-07034 type DrugProduct.
- PRX-07034 type FunctionalSubstance.
- PRX-07034 comment "PRX-07034 is a selective 5-HT6 receptor antagonist. It has cognition and memory-enhancing properties and potently decreases food intake and body weight in rodents. PRX-07034 was under development by Epix Pharmaceuticals for the treatment of obesity and cognitive impairment associated with Alzheimer's disease and schizophrenia but upon the company collapsing due to lack of funds the compound was auctioned to another corporation.".
- PRX-07034 label "PRX-07034".
- PRX-07034 sameAs m.0bbw75v.
- PRX-07034 sameAs Q855480.
- PRX-07034 sameAs Q855480.
- PRX-07034 wasDerivedFrom PRX-07034?oldid=592867718.
- PRX-07034 depiction PRX-07034_structure.png.
- PRX-07034 isPrimaryTopicOf PRX-07034.
